The company manages, promotes, sells and distributes a vast and varied portfolio of pharmaceuticals, medical devices, medical consumables, generics, food supplements, injectables, vaccines and bio-similars. The company offers its customer networks to relevant manufacturers, as agent or distributor.
The company opened its doors back in 2013 and is licensed by the Malta Medicines Authority. Their pharma business model is split into two: the main sector focuses on the private market where a team of trained sales professional promote, market and sell medicinal products on a national level. Their second section focuses on the National Healthcare Service where the company bids for government contracts. The objective is always to deliver service excellence in both sectors which means high-level training of all personnel is ongoing.
- Type of partner sought: The list of products on the Malta National Healthcare Sector keeps growing year on year and so the company seeks to partner with reputable and trusted suppliers and remain in a position as a major candidate for government contracts.
- Specific area of activity of the partner: The company is interested in working with pharmaceutical and/or medical devices companies who seek representation or assistance in targetting new markets. The partnership is envisaged under trade intermediary options.
The Maltese company offers a holistic service and is in a position to support a potential partner with all aspects of the supply chain, including strategic consultancy which allows a pharmaceutical or medical devices company to develop a new customer base. Their newly built 800m2 warehouses are GDP [Good Distribution Practice] licensed and can accommodate narcotics, biologicals and cold-chain products. The company also has a GMP [Good Manufacturing Practice] license to be able to relabel products in-house. This company would be an appropriate partner for manufacturers that intend to expand their international markets.
411 days ago - Guidance on Horizon 2020 funding if there's a no-deal Brexit